http://www.cnr.it/ontology/cnr/individuo/prodotto/ID260279

Cancer-associated genodermatoses: Skin neoplasms as clues to hereditary tumor syndromes (Articolo in rivista)

Type

Label

Cancer-associated genodermatoses: Skin neoplasms as clues to hereditary tumor syndromes (Articolo in rivista) (literal)

Anno

Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#doi

Alternative label

Ponti G. [ 1 ] ; Pellacani G. [ 2 ] ; Seidenari S. [ 2 ] ; Pollio A. [ 3 ] ; Muscatello U. [ 4 ] ; Tomasi A. [ 1 ] (2013)
Cancer-associated genodermatoses: Skin neoplasms as clues to hereditary tumor syndromes
in Critical reviews in oncology/hematology; Elsevier Science Inc., New York (Stati Uniti d'America)
(literal)

Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#autori

Ponti G. [ 1 ] ; Pellacani G. [ 2 ] ; Seidenari S. [ 2 ] ; Pollio A. [ 3 ] ; Muscatello U. [ 4 ] ; Tomasi A. [ 1 ] (literal)

Pagina inizio

Pagina fine

Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#numeroVolume

Rivista

Note

Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#affiliazioni

[ 1 ] Univ Hosp Modena & Reggio Emilia, Dept Clin & Diagnost Med & Publ Hlth, Modena, Italy [ 2 ] Univ Hosp Modena & Reggio Emilia, Div Dermatol, Dept Head & Neck Surg, Modena, Italy [ 3 ] Univ Naples Federico II, Sch Med & Surg, Dept Odontostomatol & Maxillofacial Sci, Oral Med Unit, Naples, Italy [ 4 ] Univ Modena & Reggio Emilia, CNR, Nanosci Inst, Ctr S3, Modena, Italy (literal)

Titolo

Cancer-associated genodermatoses: Skin neoplasms as clues to hereditary tumor syndromes (literal)

Abstract

Characteristic skin neoplasms are associated with a large number of hereditary tumor syndromes and their knowledge and early detection may facilitate the diagnosis of the underlying malignancies. We will review the clinical and dermatopathological aspects of cutaneous and visceral lesions and the recent progresses in understanding the etiology, pathogenesis and therapies of selected tumor syndromes. The skin neoplasms we chose to consider are multiple neurofibromas in neurofibromatosis, cylindromas and trichoepitheliomas in Broke-Spiegler syndrome, sebaceous tumors and keratoacanthomas in Muir-Torre syndrome, Gardner fibromas in Gardner syndrome, multiple basal cell carcinomas in nevoid basal cell carcinoma (Gorlin) syndrome, multiple tricholemmomas in Cowden syndrome, multiple fibrofolliculomas in Birt-Hogg-Dube syndrome and multiple leiomyomas in hereditary leiomyomatosis and renal cell cancer. Hereditary cancers have distinct biological and clinical features as compared to their sporadic counterparts; for this reason, we are now able to experiment new treatment approaches involving not only tumor detection and prevention, but also tailored therapeutic strategies focusing on the peculiar druggable molecular targets. (c) 2012 Elsevier Ireland Ltd. All rights reserved. (literal)

Editore